What is Shanghai OPM Biosciences Co., Ltd.'s (688293.SS) StockRank?

MoatMap's StockRank for Shanghai OPM Biosciences Co., Ltd. (688293.SS) is 42/100, with a Hold signal. This is a composite score combining Quality (57), Value (38), and Momentum (38) factor ranks across MoatMap's 19,000+ stock universe.

Does Shanghai OPM Biosciences Co., Ltd. have an economic moat?

Shanghai OPM Biosciences Co., Ltd. (688293.SS) has a Quality factor score of 57/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Shanghai OPM Biosciences Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Shanghai OPM Biosciences Co., Ltd. (688293.SS) is Hold, based on a StockRank of 42/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Shanghai OPM Biosciences Co., Ltd. in?

Shanghai OPM Biosciences Co., Ltd. (688293.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

688293.SS

HOLDFLAG

Shanghai OPM Biosciences Co., Ltd. · Healthcare · China · $898M · Avg Vol: $8M/d

StockRank

P/E (TTM)

115.9x

ROE

2.6%

D/E

0.1x

Dividend %

1.2%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Shanghai OPM Biosciences is a high-quality provider of cell culture media and CDMO services in China. It possesses a strong regulatory moat and high switching costs, as media formulations are locked into clinical trials. However, near-term domestic biotech funding constraints in China act as a temporary drag on growth.

COMPANY DESCRIPTION

Shanghai OPM Biosciences provides cell culture media and contract development and manufacturing organization (CDMO) services for biopharmaceuticals. The company's competitive moat lies in its proprietary, high-performance serum-free media formulations that rival international brands, coupled with integrated antibody development services. It is a leading domestic player in the upstream bioprocess consumables market, benefiting from the localization of biotech supply chains.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	44M	36M	44M	52M	6.4%
EPS	0.15	0.07	0.03	0.05	-29.1%
Shares	115M	115M	115M	114M	-0.8%
Debt	14M	10M	10M	8M	-14.7%
Equity	323M	319M	310M	310M	-1.3%
Op CF	16M	9M	10M	15M	-2.5%
Inv CF	-57M	-22M	-55M	-23M	—
Fin CF	218M	-20M	-15M	-8M	—

PRICE (1M)-28.5%

SMA 50SMA 200

$5.31

RSI (14)

22.6

52W High

$10.02

From 52W High

0.5%

SCORE BREAKDOWN

Quality

ROIC

2.4%49.3

ROE

2.6%49.6

GP/Assets

9.0%24.2

Op. Margin

8.2%61.9

FCF/Assets

36.4%98.1

Piotroski

—83.5

Int. Cover

19.3x74.4

D/E Ratio

0.06x72.1

Current Ratio

1.90x34.9

Value

P/E (TTM)

115.9x7.8

EV/EBITDA

50.3x6.6

P/FCF

50.4x90.7

P/B

1.7x61.1

P/S

11.0x24.4

Div Yield

1.2%33.3

Momentum

52W High %

53%27.7

RS 6M

-36%33.3

SMA 50/200

0.90x33.3

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

167%90.3

FUNDAMENTALS

Market Cap

$898M

P/E (Forward)

—

Gross Margin

44.6%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 688293.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
688293.SS	Shanghai OPM Biosciences Co., Ltd.(you)	$898M	42	HOLD
688767.SS	Hangzhou Biotest Biotech Co.,Ltd.	$842M	39	HOLD
301080.SZ	Acrobiosystems Co.,Ltd.	$1.0B	38	HOLD
603229.SS	Zhejiang Ausun Pharmaceutical Co., Ltd.	$1.2B	43	HOLD
300497.SZ	Jiangxi Fushine Pharmaceutical Co., Ltd.	$1.2B	41	HOLD
002880.SZ	Shenzhen Weiguang Biological Products Co., Ltd.	$845M	48	HOLD
301333.SZ	R&G PharmaStudies Co., Ltd.	$724M	38	HOLD
688739.SS	Liaoning Chengda Biotechnology Co.,Ltd.	$1.3B	42	HOLD
688658.SS	Youcare Pharmaceutical Group Co., Ltd.	$1.2B	39	HOLD
2171.HK	CARsgen Therapeutics Holdings Limited	$1.3B	39	HOLD

Peer medians: ROE 4.8% · P/E 27.6x · Gross margin 53.1%

Shanghai OPM Biosciences Co., Ltd. (688293.SS) — Stock Score Summary

Shanghai OPM Biosciences Co., Ltd. (688293.SS) has a MoatMap StockRank of 42/100 based on Quality (57/100), Value (38/100), and Momentum (38/100) factor scores. The current signal is HOLD. Shanghai OPM Biosciences is a high-quality provider of cell culture media and CDMO services in China. It possesses a strong regulatory moat and high switching costs, as media formulations are locked into clinical trials. However, near-term domestic biotech funding constraints in China act as a temporary drag on growth.

Key Financial Metrics

Price	$5.31
Market Cap	$898M
P/E (TTM)	115.87
Price/Book	1.71
Return on Equity	2.6%
Return on Invested Capital	2.4%
Debt/Equity	6.19
Gross Margin	44.6%
Operating Margin	8.2%
Revenue Growth	117.7%
Dividend Yield	1.2%
Free Cash Flow	$18M

Shanghai OPM Biosciences Co., Ltd. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Shanghai OPM Biosciences Co., Ltd.’s (688293.SS) StockRank?: MoatMap’s StockRank for Shanghai OPM Biosciences Co., Ltd. (688293.SS) is 42/100, with a Hold signal. It is a composite of Quality (57), Value (38), and Momentum (38) factor ranks across MoatMap’s 19,000+ stock universe.
Does Shanghai OPM Biosciences Co., Ltd. have an economic moat?: Shanghai OPM Biosciences Co., Ltd. (688293.SS) has a Quality factor score of 57/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Shanghai OPM Biosciences Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Shanghai OPM Biosciences Co., Ltd. (688293.SS) is Hold, based on a StockRank of 42/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Shanghai OPM Biosciences Co., Ltd. in?: Shanghai OPM Biosciences Co., Ltd. (688293.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).